CLNN
Clene Inc
About CLNN
Clene Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the treatment of neurodegenerative disease with potential first-in-class nanotherapeutics to treat energetic failure and neurological diseases. The Company’s lead drug candidate, CNM-Au8, is an oral suspension of gold nanocrystals that drive critical cellular energetic metabolism in the central nervous system (CNS). CNM-Au8 increases energy production and utilization to accelerate neurorepair and improve neuroprotection. CNM-Au8 is being evaluated in a Phase III registration trial in amyotrophic lateral sclerosis (ALS) and a Phase II trial for the treatment of chronic optic neuropathy in patients with stable relapsing multiple sclerosis (MS). The Company has also advanced into the clinic an aqueous solution of ionic zinc and silver for anti-viral and anti-microbial uses.
Buy US stocks in Australia starting with CLNN. Open an account and start investing today!
$90.78M
-
0.00%
154.22K
$1.24
$1.17
$1.18
$5.13
$0.87
CLNN FAQs
To do so follow these steps:
- Sign up in minutes, all you need is some I.D.
- Choose Stake Wall St
- Deposit directly into your Stake wallet and you're ready to invest in CLNN
Related Stocks
This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.